Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis: Multicentre Retrospective Study of 209 Patients
Rheumatology (Oxford) 2022 Apr 11;61(4)1376-1384, A Mekinian, L Biard, L Dagna, P Novikov, C Salvarani, O Espitia, S Sciascia, M Michaud, M Lambert, J Hernández-Rodríguez, N Schleinitz, A Awisat, X Puéchal, A Aouba, H Munoz Pons, I Smitienko, JB Gaultier, E Le Mouel, Y Benhamou, A Perlat, P Jego, T Goulenok, K Sacre, B Lioger, N Hassold, J Broner, V Dufrost, T Sene, J Seguier, F Maurier, S Berthier, A Belot, F Frikha, G Denis, A Audemard-Verger, I Kone Pault, S Humbert, P Woaye-Hune, A Tomelleri, E Baldissera, M Kuwana, A Lo Gullo, F Gaches, P Zeminsky, E Galli, M Alvarado, L Boiardi, F Muratore, M Vautier, C Campochiaro, S Moiseev, P Cacoub, O Fain, D SaadounFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.